FDA, Industries Reach Tentative Pact on User-Fee Act

Biotech: More Funds Needed to Improve Drug Approval Process

BY MARION WEBB
Senior Staff Writer

The biotechnology and pharmaceutical industries and the Food and Drug Administration announced recommendations on renewing a user-fee law that would allow the agency to collect more money and improve the approval process of drugs...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129